$RNA
Atrium Therapeutics, Inc. Common Stock
XNAS
Why is RNA up today? It is at $12.13 (+3.32%). See the catalyst behind the move, real-time alerts the moment RNA spikes, and full due diligence on RNA — key stats, earnings, dilution and insider activity. Free.
Get free $RNA alerts the moment volume spikes
Be first to know when $RNA makes an unusual move. Create a free account to track $RNA, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $12.13
- Change today
- +3.32%
- Previous close
- $11.74
- 52-week range
- $11.13 – $73.06
- Market cap
- $201M
- Short interest
- 3.6M ▼ -2% vs prior · as of 2026-07-15
- Short % of float
- 21.0%
- Days to cover
- 17.7d
- Avg daily volume
- 2.3M
- Next earnings
- Aug 13 · in 7d
- Exchange
- XNAS
- 5m
- 0.3x
- 15m
- 0.7x
- 1h
- 0.7x
- 1D
- 0.0x
Get free RNA + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $RNA up today?
Here is the latest on RNA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Insiders
0 buys, 0 sells last 3 months (6/0 over 12 months)Show 6 recent transactionsMinimize 6 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Younis Husam Officer | Acquired (grant/award) | +30K 0.2% of company | added 100% | 53K | n/a | Apr 20, 26 |
Hoyos Rocio Martin Officer | Acquired (grant/award) | +30K 0.2% of company | added 100% | 47K | n/a | Apr 20, 26 |
Gallagher Kathleen P. Officer | Acquired (grant/award) | +103K 0.6% of company | added 100% | 131K | n/a | Apr 20, 26 |
Winslow Brendan R. Officer | Acquired (grant/award) | +30K 0.2% of company | added 100% | 44K | n/a | Apr 20, 26 |
Hughes Steven George Officer | Acquired (grant/award) | +30K 0.2% of company | added 70% | 73K | n/a | Apr 20, 26 |
Kenney Stephanie Officer | Acquired (grant/award) | +30K 0.2% of company | added 100% | 35K | n/a | Apr 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
$RNA Sentiment
BearishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$RNA Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
RNA stock FAQ
Why is $RNA up today?
Here is the latest on RNA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the RNA stock price today?
RNA last traded at $12.13, up 3.32% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does RNA report earnings?
Atrium Therapeutics, Inc. Common Stock (RNA) is next expected to report earnings on Thursday, August 13, 2026, about 7 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live RNA alerts?
The RNA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RNA 0 times in the last 30 days.
What exchange is RNA on?
RNA (Atrium Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $201M.
Is RNA good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RNA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.